Julien Lagarde

9PUBLICATIONS
71CO-AUTHORS
Environmental studies in animal productionAutomotive engineering materialsMedical molecular engineering of nucleic acids and proteinsPsychology of ageingForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.

Rik Ossenkoppele, Emma M Coomans, Liana G Apostolova

|Mar 17, 2025
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.

Julien Lagarde, Piyush Maiti, Daniel R Schonhaut

|Jun 05, 2024
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease.

Marie Sarazin, Julien Lagarde, Inès El Haddad

|Apr 04, 2023
Increased plasma DYRK1A with aging may protect against neurodegenerative diseases.

Jean M Delabar, Julien Lagarde, Marta Fructuoso

|Feb 14, 2023
Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer's disease patients are associated with cognitive impairment.

Laura Xicota, Julien Lagarde, Fanny Eysert

|Mar 01, 2022
Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer's disease.

Julien Lagarde, Pauline Olivieri, Matteo Tonietto

Pageof 2

Frequent Collaborators

4 joint publications

Marie Sarazin

3 joint publications

Michel Bottlaender

2 joint publications

Isabelle Rivals

2 joint publications

Marie-Claude Potier